CIK 0001393434 · Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Dugel Pravin See Remarks | Gift | +49,754 | 49,754 | ||
| 2025-09-02 | Notman Donald See Remarks | Sale | −1,066 | $12.43 | $13K | 308,807 |
| 2025-08-25 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −3,011 | $12.04 | $36K | 204,093 |
| 2025-08-25 | Nayak Sanjay Chief Strategy Officer | Sale 10b5-1 | −1,885 | $12.04 | $23K | 279,738 |
| 2025-08-25 | Heier Jeffrey S. Chief Scientific Officer | Sale 10b5-1 | −3,063 | $12.04 | $37K | 259,911 |
| 2025-08-25 | Dugel Pravin See Remarks | Sale 10b5-1 | −21,494 | $12.04 | $259K | 3,227,244 |
| 2025-08-12 | Waheed Nadia Chief Medical Officer | Grant or award | +40,363 | 247,168 | ||
| 2025-08-12 | Waheed Nadia Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +122,923 | 122,923 | ||
| 2025-08-11 | Dugel Pravin See Remarks | Gift | +250,361 | 250,361 | ||
| 2025-06-12 | Dugel Pravin See Remarks | Gift | −50,029 | 3,248,738 | ||
| 2025-06-11 | Dugel Pravin See Remarks | Grant or award · Performance Stock Option (Right to Buy) | +2,750,000 | 2,750,000 | ||
| 2025-06-11 | Hong Seung Suh Director | Grant or award | +14,000 | 46,933 | ||
| 2025-06-11 | Hong Seung Suh Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2025-06-11 | RAINES MERILEE Director | Grant or award | +14,000 | 46,933 | ||
| 2025-06-11 | RAINES MERILEE Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2025-06-11 | LINDSTROM RICHARD L MD Director | Grant or award | +14,000 | 143,145 | ||
| 2025-06-11 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2025-06-11 | Williams Leslie J. Director | Grant or award | +14,000 | 51,433 | ||
| 2025-06-11 | Williams Leslie J. Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2025-06-11 | Warden Charles M Director | Grant or award | +14,000 | 86,464 |
Page 5 of 8 · 158 trades